RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 58 filers reported holding RAIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,309 | -25.5% | 8,481 | +3.7% | 0.00% | – |
| Q2 2023 | $9,816 | -75.5% | 8,180 | +3.6% | 0.00% | – |
| Q1 2022 | $40,000 | -63.3% | 7,899 | -6.6% | 0.00% | -100.0% |
| Q4 2021 | $109,000 | +75.8% | 8,455 | +104.3% | 0.00% | – |
| Q3 2021 | $62,000 | -4.6% | 4,139 | -0.5% | 0.00% | – |
| Q2 2021 | $65,000 | – | 4,158 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,637,308 | $25,444,000 | 3.14% |
| Cormorant Asset Management, LP | 2,626,660 | $39,734,000 | 1.35% |
| BVF INC/IL | 1,945,949 | $30,240,000 | 1.13% |
| Logos Global Management LP | 780,331 | $12,126,000 | 1.02% |
| ACUTA CAPITAL PARTNERS, LLC | 162,245 | $2,521,000 | 1.01% |
| LUMINUS MANAGEMENT LLC | 425,000 | $6,605,000 | 0.96% |
| Boxer Capital, LLC | 1,175,000 | $18,260,000 | 0.64% |
| Perceptive Advisors | 5,074,038 | $78,850,000 | 0.51% |
| Lumina Fund Management LLC | 6,000 | $93,000 | 0.04% |
| Monashee Investment Management LLC | 20,000 | $311,000 | 0.04% |